U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07414420) titled 'Oral Dynamic Propulsion Appliance in Treatment of Patients With Obstructive Sleeping Apnea' on Feb. 09.
Brief Summary: Obstructive Sleep Apnea (OSA) is one of the most prevalent sleep disorders, affecting nearly one billion people worldwide. It is characterized by repeated episodes of complete (apnea) or partial (hypopnea) obstruction of the upper airway during sleep, leading to snoring, excessive daytime sleepiness, insomnia, morning headaches, nocturia, behavioral changes, reduced concentration, and serious cardiovascular and metabolic complications such as insulin resistance, type II diabetes, and metabolic syndrome. During the n...